Patient Organization Provides Input to Affect Clinical Trial Design and Exclusion Criteria
Source
Clinical Trials Transformation Initiative (CTTI)
Link
CTTI Recommendations: Patient Group Engagement
Description of Case Study
The Foundation for Prader-Willi Research worked with a trial sponsor to revise protocol exclusion criteria after identifying that commonly used medications among the target patient population would limit recruitment. These changes were made to ensure broader patient eligibility, avoiding recruitment challenges and potential delays in the trial timeline.
Quick Facts Organization name: Foundation for Prader-Willi Research |
Product Type(s)
- pharmaceutical/biological product
Stakeholders
- medtech company: internal discovery/research and development teams
- patients and caregivers, patient organizations
Methods and Sources of Patient Input
- patient advocacy organizations
- advisory committee participation (including Data and Safety Monitoring Board)
- patient-developed solutions
Impact of Patient Engagement
- Protocol design refinement: Patient organization input identified commonly used medications that conflicted with exclusion criteria, leading to revisions to better reflect real-world treatment patterns.
- Improved recruitment feasibility: Changes broadened the eligible population, increasing the feasibility of enrollment based on actual patient medication use.
- Reduced participation barriers: Aligning criteria with real-world conditions reduced barriers that could limit participation and slow enrollment.
Lessons Learned
- Patient organizations can identify real-world barriers: Patients are uniquely positioned to share their lived experience and inform what will and will not work to allow for their participation in a clinical trial.
- Eligibility criteria should reflect real-world use: Aligning criteria with patient populations can improve recruitment.
- Early engagement can prevent delays: Identifying eligibility barriers earlier in design can reduce the risk of recruitment issues and timeline impacts during study operations.